SO
ALNY icon

Sierra Ocean’s Alnylam Pharmaceuticals ALNY Stock Holding History

Sierra Ocean’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-68
Closed -$22.2K – 96
2025
Q2 		$22.2K Sell
68
-3
-4% -$830 0.02% 306
2025
Q1 		$19.2K Buy
71
+5
+8% +$1.28K 0.02% 309
2024
Q4 		$15.5K Buy
+66
New +$17.4K 0.01% 335

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Sierra Ocean's ALNY Position: Q3 2025 in Review

Sierra Ocean sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2025, closing a stake of 68 shares — an estimated $22.2K sold.

Sierra Ocean first reported a position in ALNY in Q4 2024 and held it in 3 quarters. The position peaked at $22.2K in Q2 2025. 823 funds tracked by Wall St. Rank hold ALNY as of Q3 2025.

  • Sierra Ocean reported no remaining Alnylam Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Sierra Ocean sold 68 Alnylam Pharmaceuticals shares in Q3 2025, an estimated $22.2K.
  • Sierra Ocean first reported a position in Alnylam Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Sierra Ocean's Alnylam Pharmaceuticals position peaked at $22.2K in Q2 2025.
  • 823 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2025.

Based on Sierra Ocean's 13F filing for Q3 2025, filed 7 Nov 2025.